Study wrapper · #408
Enhanced Stability and Transdermal Delivery of Semaglutide Using an L-Arginine Based Dissolving Microneedle System.
Editor's note
This is a pharmaceutical formulation study — laboratory and ex-vivo, not clinical — developing a dissolving-microneedle (DMN) skin patch to deliver semaglutide without an injection or the oral bioavailability problem. The notable technical claim is using L-arginine as an excipient to stabilize the peptide, which the authors describe as a first. They characterized the arrays for mechanical strength, insertion into synthetic film and ex-vivo porcine skin, 12-hour release, and dye penetration by imaging. Crucially, this is a delivery-and-stability proof-of-concept: the work demonstrates that the patch can be made and can deposit material into skin, and the authors themselves acknowledge persisting challenges around loss of therapeutic activity and peptide stability. There is no measurement of drug absorption, blood levels, glucose or weight effects in any living subject. These are preclinical device findings; human data would be needed before any clinical conclusions about a semaglutide patch.
Plain-language abstract
Semaglutide is usually given as an injection and is hard to deliver as a pill because little of it is absorbed. This laboratory study tested a possible alternative: a small skin patch covered in tiny 'microneedles' that dissolve after being pressed into the skin. Researchers built the patch from water-soluble materials and added an amino acid, L-arginine, to help keep the semaglutide stable — which they say had not been done this way before. They measured how strong the needles were, how well they pierced a test film and pig skin, how the drug released over 12 hours, and used imaging with a dye to show material entering the skin. The results suggest the patch can be manufactured and can push its contents into skin. However, the authors caution that keeping the peptide fully active and stable remains a challenge. This was a bench and animal-skin study; it did not measure drug levels or effects in a living body, so human testing would be needed.